DataMeds AI, Inc. (MEDS): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:15 ET
- Event date
- 2026-11-13
- Accession no.
- 0001493152-26-051734
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
DataMEDS AI reports third quarter 2026 results and restored Nasdaq compliance
DataMEDS AI reported third quarter 2026 net revenues of $2,668,980, compared with $3,012,904 a year earlier. Net income was $10,535,560, including a $19,064,881 gain on extinguishment of debt, while loss from operations was $3,373,956. The company also disclosed restored Nasdaq compliance and a non-binding HMO memorandum of understanding.
- Third quarter 2026 revenue was $2.7 million, up 50% from $1.8 million in the second quarter of 2026.
- Diluted earnings per share were $2.72 for the quarter ended September 30, 2026.
- DataMEDS AI regained full compliance with Nasdaq listing standards on October 19, 2026.
- In November 2026, the company signed a non-binding MOU with a Florida-based HMO to deploy Health Lives Here to 25,000+ members.
earningslisting notice
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | form8-k.htm |
| EX-99.1 | EX-99.1 | ex99-1.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.